Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Pabitra Basnyat"'
Autor:
Niina Lähde, Pabitra Basnyat, Jani Raitanen, Kai Lehtimäki, Eija Rosti‐Otajärvi, Jukka Peltola
Publikováno v:
Epilepsia Open, Vol 9, Iss 1, Pp 150-163 (2024)
Abstract Objective To investigate executive functions and attention with repeated EpiTrack evaluations in a group of DR patients with drug‐resistant epilepsy (DRE) receiving vagus nerve stimulation (VNS) during a follow‐up duration of up to 5 yea
Externí odkaz:
https://doaj.org/article/b05c63fbf7b24e06b2e2d933de7e4777
Autor:
Niina Lähde, Pabitra Basnyat, Jani Raitanen, Leena Kämppi, Kai Lehtimäki, Eija Rosti-Otajärvi, Jukka Peltola
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
IntroductionThere is a paucity of clinical studies examining the long-term effects of vagus nerve stimulation (VNS) on cognition, although a recent study of patients with drug-resistant epilepsy (DRE) treated with VNS therapy demonstrated significant
Externí odkaz:
https://doaj.org/article/2c7f6e62ec8541468de29afb55a7bcb6
Autor:
Pabitra Basnyat, Maria Peltola, Jani Raitanen, Suvi Liimatainen, Sirpa Rainesalo, Marko Pesu, Jukka Peltola
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 17 (2023)
BackgroundAntibodies against glutamic acid decarboxylase (GADA) are present in multiple neurological manifestations, such as stiff-person syndrome, cerebellar ataxia, limbic encephalitis, and epilepsy. Increasing data support the clinical significanc
Externí odkaz:
https://doaj.org/article/423a97f508ff4b8abb04d7776d8c0ff8
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract The aim of this study was to evaluate the effects of deep brain stimulation of the anterior nucleus of the thalamus (ANT-DBS) on systemic inflammatory responses in patients with drug-resistant epilepsy (DRE). Twenty-two Finnish patients with
Externí odkaz:
https://doaj.org/article/3eb092a38bce42ac804b62bfdb577a75
Autor:
Pabitra Basnyat, Marko Pesu, Mikael Söderqvist, Anna Grönholm, Suvi Liimatainen, Maria Peltola, Jani Raitanen, Jukka Peltola
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Increasing evidence supports the role of soluble inflammatory mediators in the pathogenesis of refractory temporal lobe epilepsy (TLE). Hippocampal sclerosis (HS) is a well-described pathohistological abnormality in TLE. The assoc
Externí odkaz:
https://doaj.org/article/55efa2ee1c4a43cd95bb08dc2f28e782
Publikováno v:
Acta Neurologica Scandinavica.
Background. Several studies have reported the association of the proinflammatory cytokine IL-6 with temporal lobe epilepsy (TLE), but the regulation of IL-6 in hippocampal sclerosis (HS) is less studied. Objectives. To analyse IL-6 levels and the IL-
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Scientific Reports
Scientific Reports
The aim of this study was to evaluate the effects of deep brain stimulation of the anterior nucleus of the thalamus (ANT-DBS) on systemic inflammatory responses in patients with drug-resistant epilepsy (DRE). Twenty-two Finnish patients with ANT-DBS
Publikováno v:
Epilepsybehavior : EB. 133
Objective: The aim of this study was to evaluate the clinical utility of a semi-automated hybrid video/audio-based epilepsy monitoring system (Nelli®) in a home setting. Methods: In this retrospective study, 104 consecutive patients underwent Nelli-
Autor:
Suvi Liimatainen, Maria Peltola, Marko Pesu, Jani Raitanen, Pabitra Basnyat, Anna Grönholm, Jukka Peltola, Mikael Söderqvist
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Neurology
BMC Neurology
BackgroundIncreasing evidence supports the role of soluble inflammatory mediators in the pathogenesis of refractory temporal lobe epilepsy (TLE). Hippocampal sclerosis (HS) is a well-described pathohistological abnormality in TLE. The association of
Autor:
Rebecca, Kiiski, Pabitra, Basnyat, Jani, Raitanen, Sirpa, Rainesalo, Jukka, Peltola, Jussi, Mäkinen
Publikováno v:
Acta neurologica Scandinavica. 145(4)
To evaluate the changes in prescription patterns in the treatment of idiopathic generalized epilepsy (IGE) due to updated treatment recommendations and to assess seizure outcomes of valproate compared to other antiseizure medications (ASMs), with emp